Naproxen Aflofarm 5909990956913

Naproxen Aflofarm

Naproxen Aflofarm is used to treat mild to moderate pain ailments such as:        

  • pain associated with muscle and joint diseases such as light sprains, post-workout damage, and lumbar pain;
  • dysmenorrhea.

Pharmaceutical form tablets. 200 mg - 10 tab.

Category OTC

Additional information

Dosage and administration: Oral use.

- Ad hoc pain relief 2 tablets (400 mg) at once, followed by 1 tablet every 6 to 8 hours if necessary. A daily dose of 600 mg must not be exceeded.
The medicinal product should not be used for more than 10 days in case of pain without clear medical indications.
Undesirable effects may be minimized by using the lowest effective dose for the shortest duration necessary to resolve symptoms.

Dosage in the elderly
Due to the fact that the elderly are more susceptible to adverse reactions, lower doses should be considered.

Dosage in children
Safety in children has not been established. Do not use in children under 16 years of age.

Dosage in people with severe kidney, liver or heart problems:
The dose may need to be reduced in people with severe kidney, liver or heart problems.

Active substance

One tablet contains 200 mg of naproxen (Naproxenum). Excipients with known effect: 1 tablet contains 38.9 mg of lactose monohydrate and sunset yellow (E 110).


Treatment of low and moderate pain ailments, such as:

  • pain associated with muscle and joint diseases such as light sprains, post-workout damage, and lumbar pain;
  • dysmenorrhea.


Hypersensitivity towards the active substance or to any of the excipients.

  • Hypersensitivity towards acetylsalicylic acid and other non-steroidal anti-inflammatory drugs (NSAIDs).
  • History of bronchial asthma, urticaria or allergic reaction after taking acetylsalicylic acid or other NSAIDs.
  • Gastrointestinal bleeding or perforation related to a history of past NSAIDs.
  • Gastric and duodenal ulcer (active or confirmed), perforation or bleeding, also occurring after use of NSAIDs (two or more distinct episodes of confirmed ulceration or bleeding).
  • Haemorrhagic diathesis.
  • Severe heart failure.
  • Severe renal or hepatic impairment.
  • Third trimester of pregnancy.

Marketing Authorisation Holder

Aflofarm Farmacja Polska Spółka z o.o.

Marketing Authorisation


Information for the patient

Read the package leaflet for indications, contraindications, side effects, dosage as well as information on the use of this product, or consult your doctor or pharmacist before use. Misusing medicines may be dangerous to your life or health.

See how we care about quality

All our products are subject to strict safety requirements

We use rigorous quality control standards and procedures to ensure the highest level of safety for all our products.

See how we care about safety
This site uses cookies for services in accordance with the Privacy Policy